142 related articles for article (PubMed ID: 38195570)
1. Development and evaluation of the Newstage system: integrating tumor regression grade and lymph node status for improved prognostication in neoadjuvant treatment of gastric cancer.
Chen M; Yu S; Chen C; Liang J; Zhou D
World J Surg Oncol; 2024 Jan; 22(1):16. PubMed ID: 38195570
[TBL] [Abstract][Full Text] [Related]
2. A Novel Tumor Staging System Incorporating Tumor Regression Grade (TRG) With Lymph Node Status (ypN-Category) Results in Better Prognostication Than ypTNM Stage Groups After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
Wong IYH; Chung JCY; Zhang RQ; Gao X; Lam KO; Kwong DLW; Chao YK; Law SYK
Ann Surg; 2022 Nov; 276(5):784-791. PubMed ID: 35876374
[TBL] [Abstract][Full Text] [Related]
3. Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: A Multi-Institutional Study.
Zhong Q; Chen QY; Parisi A; Ma YB; Lin GT; Desiderio J; Yan S; Xie JW; Wang JB; Hou JF; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Liu ZY; Que SJ; Li P; Zheng CH; Huang CM
Oncologist; 2021 Jan; 26(1):e99-e110. PubMed ID: 32864840
[TBL] [Abstract][Full Text] [Related]
4. Proposed modification of the eighth edition of the AJCC-ypTNM staging system of esophageal squamous cell cancer treated with neoadjuvant chemotherapy: Unification of the AJCC staging system and the Japanese classification.
Oshikiri T; Goto H; Kato T; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Kakeji Y
Eur J Surg Oncol; 2022 Aug; 48(8):1760-1767. PubMed ID: 35094909
[TBL] [Abstract][Full Text] [Related]
5. Validation of the post-neoadjuvant staging system of the American joint committee on cancer, 8th edition, in patients treated with neoadjuvant chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma.
Kang J; Lee HP; Kim HR; Kim JH; Jung HY; Lee GH; Song HJ; Kim DH; Choi KD; Ahn JY; Ryu JS; Cho KJ; Lee MY; Kim SB; Kim YH; Park SR
Surg Oncol; 2020 Dec; 35():491-497. PubMed ID: 33130441
[TBL] [Abstract][Full Text] [Related]
6. A Novel ypTLM Staging System Based on LODDS for Gastric Cancer After Neoadjuvant Therapy: Multicenter and Large-Sample Retrospective Study.
Que SJ; Zhong Q; Chen QY; Truty MJ; Yan S; Ma YB; Ding FH; Zheng CH; Li P; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Lin JL; Zheng HL; Huang CM
World J Surg; 2023 Jul; 47(7):1762-1771. PubMed ID: 37069317
[TBL] [Abstract][Full Text] [Related]
7. Topographic lymph node staging system shows prognostic superiority compared to the 8th edition of AJCC TNM in gastric cancer. A western monocentric experience.
Lauricella S; Caricato M; Mascianà G; Carannante F; Carnazza M; Bonaccorso A; Angeletti S; Ciccozzi M; Coppola R; Capolupo GT
Surg Oncol; 2020 Sep; 34():223-233. PubMed ID: 32869748
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the predictive value of pathological response at primary tumor and lymph node status after neoadjuvant chemotherapy in locally advanced gastric cancer.
Su P; Zhang Y; Yu T; Jiang L; Kang W; Liu Y; Yu J
Clin Transl Oncol; 2023 Aug; 25(8):2462-2471. PubMed ID: 37093455
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of prognostic model based on extragastric lymph nodes metastasis and lymph node ratio in node-positive gastric cancer: a retrospective cohort study based on a multicenter database.
Zeng Y; Cai F; Wang P; Wang X; Liu Y; Zhang L; Zhang R; Chen L; Liang H; Ye Z; Deng J
Int J Surg; 2023 Apr; 109(4):794-804. PubMed ID: 36999785
[TBL] [Abstract][Full Text] [Related]
10. ypTNM staging after neoadjuvant chemotherapy in the Chinese gastric cancer population: an evaluation on the prognostic value of the AJCC eighth edition cancer staging system.
Li Z; Wang Y; Shan F; Ying X; Wu Z; Xue K; Miao R; Zhang Y; Ji J
Gastric Cancer; 2018 Nov; 21(6):977-987. PubMed ID: 29748876
[TBL] [Abstract][Full Text] [Related]
11. A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes.
Seeruttun SR; Xu L; Wang F; Yi X; Fang C; Liu Z; Wang W; Zhou Z
Cancer Commun (Lond); 2019 Jun; 39(1):32. PubMed ID: 31182160
[TBL] [Abstract][Full Text] [Related]
12. Imaging lymph node regression can predict the pathological tumor regression grade in gastric cancer after neoadjuvant treatment.
Meng F; Yang Y; Wang X; Cai F; Liang H; Zhang R; Deng J
Surgery; 2023 Oct; 174(4):836-843. PubMed ID: 37562986
[TBL] [Abstract][Full Text] [Related]
13. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004
[No Abstract] [Full Text] [Related]
14. Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: a SEER cohort-based study.
Wang Q; Wang S; Sun Z; Cao M; Zhao X
BMC Cancer; 2022 Jul; 22(1):801. PubMed ID: 35858848
[TBL] [Abstract][Full Text] [Related]
15. Does the ypTNM-stage adequately predict long-term survival rates in gastric cancer patients receiving neoadjuvant chemotherapy followed by radical resection?
Sandø AD; Grønbech JE; Bringeland EA
Acta Oncol; 2023 Dec; 62(12):1846-1853. PubMed ID: 37903117
[TBL] [Abstract][Full Text] [Related]
16. Anatomical location-based nodal staging system is superior to the 7th edition of the American Joint Committee on Cancer staging system among patients with surgically resected, histologically low-grade gastric cancer: A single institutional experience.
Chen MW; Chan CP; Lin YJ; Yen HH
PLoS One; 2019; 14(2):e0211836. PubMed ID: 30721261
[TBL] [Abstract][Full Text] [Related]
17. Lymph node ratio-based the ypTNrM staging system for gastric cancer after neoadjuvant therapy: a large population-based study.
Chen JX; Sun JW; Wang Y; Pan T; Zhuang LP; Lin LZ; Lv BC
Surg Today; 2022 May; 52(5):783-794. PubMed ID: 34724107
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a staging system for gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy with D2 lymphadenectomy.
Lin JX; Yoon C; Desiderio J; Yi BC; Li P; Zheng CH; Parisi A; Huang CM; Strong VE; Yoon SS
Br J Surg; 2019 Aug; 106(9):1187-1196. PubMed ID: 31197829
[TBL] [Abstract][Full Text] [Related]
19. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer].
Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201
[No Abstract] [Full Text] [Related]
20. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
[No Abstract] [Full Text] [Related]
[Next] [New Search]
